{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:40Z","timestamp":1786982200323,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12029-020-00419-7","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:02:37Z","timestamp":1592946157000},"page":"634-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study"],"prefix":"10.1007","volume":"52","author":[{"given":"Tulay","family":"Kus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokmen","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulku Yalcintas","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Murat","family":"Sedef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva Yesil","family":"Cinkir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Dirikoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsum","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuriye Yildirim","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137\u201350.","journal-title":"J Clin Oncol"},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"52307","DOI":"10.18632\/oncotarget.10740","volume":"7","author":"M Riihim\u00e4ki","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7:52307\u201316.","journal-title":"Oncotarget."},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30:2327\u201333.","journal-title":"J Clin Oncol"},{"key":"419_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet"},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236\u201342.","journal-title":"Br J Surg"},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.radonc.2012.08.017","volume":"104","author":"JS Chang","year":"2012","unstructured":"Chang JS, Lim JS, Noh SH, Hyung WJ, An JY, Lee YC, et al. Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy. Radiother Oncol. 2012;104:367\u201373.","journal-title":"Radiother Oncol"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"20170594","DOI":"10.1259\/bjr.20170594","volume":"91","author":"W Yang","year":"2018","unstructured":"Yang W, Hu R, Li GC, Zhou ML, Wang Y, Shen LJ, et al. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study. Br J Radiol. 2018;91:20170594.","journal-title":"Br J Radiol"},{"key":"419_CR8","first-page":"353","volume":"11","author":"A Ahmed","year":"2011","unstructured":"Ahmed A, Ukwenya AY, Makama JG. Mohammad I management and outcome of gastric carcinoma in Zaria. Nigeria Afr Health Sci. 2011;11:353\u201361.","journal-title":"Nigeria Afr Health Sci"},{"key":"419_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","volume":"87","author":"Y Maehara","year":"2000","unstructured":"Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87:353\u20137.","journal-title":"Br J Surg"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10120-013-0306-2","volume":"17","author":"JH Lee","year":"2014","unstructured":"Lee JH, Son SY, Lee CM, Ahn SH, Park DJ, Kim HH. Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy. Gastric Cancer. 2014;17:529\u201336.","journal-title":"Gastric Cancer"},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/0360-3016(90)90344-J","volume":"19","author":"J Landry","year":"1990","unstructured":"Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys. 1990;19:1357\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"419_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/BF02303859","volume":"5","author":"EC Burke","year":"1998","unstructured":"Burke EC, Karpeh MS Jr, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol. 1998;5:411\u20135.","journal-title":"Ann Surg Oncol"},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","volume":"240","author":"M D'Angelica","year":"2004","unstructured":"D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808\u201316.","journal-title":"Ann Surg"},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.3748\/wjg.v20.i19.5679","volume":"20","author":"F Berlth","year":"2014","unstructured":"Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol. 2014;20:5679\u201384.","journal-title":"World J Gastroenterol"},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2016.11.067","volume":"211","author":"Y Wei","year":"2017","unstructured":"Wei Y, Wang T, Song H, Tian L, Lyu G, Zhao L, et al. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy. J Surg Res. 2017;211:266\u201378.","journal-title":"J Surg Res"},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000329075","volume":"80","author":"C Shi","year":"2011","unstructured":"Shi C, Yang B, Chen Q, Yang J, Fan N. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer. Oncology. 2011;80:289\u201395.","journal-title":"Oncology."},{"key":"419_CR17","doi-asserted-by":"crossref","unstructured":"Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, Nakajima T, et al. ; Gastric Cancer Surgical Study Group in the Japan Clinical Oncology Group. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206\u20132. Gastric Cancer. 2011;14:212\u20138.","DOI":"10.1007\/s10120-011-0027-3"},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1245\/s10434-007-9487-4","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14:2702\u201313.","journal-title":"Ann Surg Oncol"},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.7314\/APJCP.2012.13.9.4379","volume":"13","author":"JY Huang","year":"2012","unstructured":"Huang JY, Xu YY, Sun Z, Zhu Z, Song YX, Guo PT, et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:4379\u201385.","journal-title":"Asian Pac J Cancer Prev"},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/1471-2407-12-526","volume":"12","author":"J Sun","year":"2012","unstructured":"Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;12:526.","journal-title":"BMC Cancer"},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/02656736.2013.768359","volume":"29","author":"DH Mi","year":"2013","unstructured":"Mi DH, Li Z, Yang KH, Cao N, Lethaby A, Tian JH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperth. 2013;29:156\u201367.","journal-title":"Int J Hyperth"},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00419-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T09:23:08Z","timestamp":1628587388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00419-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00419-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"24 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Institutional Ethics Committee and conducted in compliance with the ethical principles according to the Declaration of Helsinki","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}